Form D — Swift Cardiovascular, Inc.
0002117135-26-000001 · filed Sep 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $1,500,000
- Reported amount sold
- $810,000
- Minimum investment
- $0
- Investors
- 7
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Swift Cardiovascular, Inc.
- CIK
- 2117135
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 110 SWIFT AVENUE
DURHAM, NC 27705 - Phone
- 919-630-7851
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jeffrey Harold Lawson · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Kemal Vincent Schankereli · DirectorDurham, NC Find on LinkedIn ↗
-
Howard Vincent Kelly · DirectorDurham, NC Find on LinkedIn ↗
-
Richard Francis Murphy · Executive OfficerDurham, NC Find on LinkedIn ↗
-
Jospeh Blakely Long · Executive OfficerDurham, NC Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗